Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection.
The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately raised the price to $750 a tablet from $13.50, bringing the annual cost of treatment for some patients to hundreds of thousands of dollars.
What is it that they are doing differently that has led to this dramatic increase? said Dr. Judith Aberg, the chief of the division of infectious diseases at the Icahn School of Medicine at Mount Sinai. She said the price increase could force hospitals to use alternative therapies that may not have the same efficacy.
Turings price increase is not an isolated example. While most of the attention on pharmaceutical prices has been on new drugs for diseases like cancer , hepatitis C and high cholesterol , there is also growing concern about huge price increases on older drugs, some of them generic, that have long been mainstays of treatment.
Photo
Martin Shkreli is the founder and chief executive of Turing Pharmaceuticals, which raised the price of the drug Daraprim to $750 a tablet from $13.50. Credit Paul Taggart/Bloomberg, via Getty Images
Although some price increases have been caused by shortages, others have resulted from a business strategy of buying old neglected drugs and turning them into high-priced specialty drugs.
Cycloserine, a drug used to treat dangerous multidrug-resistant tuberculosis, was just increased in price to $10,800 for 30 pills from $500 after its acquisition by Rodelis Therapeutics. Scott Spencer, general manager of Rodelis, said the company needed to invest to make sure the supply of the drug remained reliable. He said the company provided the drug free to certain needy patients.
In August, two members of Congress investigating generic drug price increases wrote to Valeant Pharmaceuticals after that company acquired two heart drugs, Isuprel and Nitropress, from Marathon Pharmaceuticals and promptly raised their prices by 525 percent and 212 percent respectively. Marathon had acquired the drugs from another company in 2013 and had quintupled their prices, according to the lawmakers , Senator Bernie Sanders , the Vermont independent who is seeking the Democratic nomination for president, and Representative Elijah E. Cummings, Democrat of Maryland.
Doxycycline, an antibiotic , went from $20 a bottle in October 2013 to $1,849 by April 2014 , according to the two lawmakers.
The Infectious Diseases Society of America and the HIV Medicine Association sent a joint letter to Turing earlier this month calling the price increase for Daraprim unjustifiable for the medically vulnerable patient population and unsustainable for the health care system. An organization representing the directors of state AIDS programs has also been looking into the price increase, according to doctors and patient advocates.
Daraprim, known generically as pyrimethamine, is used mainly to treat toxoplasmosis , a parasite infection that can cause serious or even life-threatening problems for babies born to women who become infected during pregnancy , and also for people with compromised immune systems, like AIDS patients and certain cancer patients.
Martin Shkreli, the founder and chief executive of Turing, said that the drug is so rarely used that the impact on the health system would be minuscule and that Turing would use the money it earns to develop better treatments for toxoplasmosis, with fewer side effects.
This isnt the greedy drug company trying to gouge patients, it is us trying to stay in business, Mr. Shkreli said. He said that many patients use the drug for far less than a year and that the price was now more in line with those of other drugs for rare diseases.
This is still one of the smallest pharmaceutical products in the world, he said. It really doesnt make sense to get any criticism for this.
http://www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html
"This is not the first time the 32-year-old Mr. Shkreli, who has a reputation for both brilliance and brashness, has been the center of controversy. He started MSMB Capital, a hedge fund company, in his 20s and drew attention for urging the Food and Drug Administration not to approve certain drugs made by companies whose stock he was shorting.
In 2011, Mr. Shkreli started Retrophin, which also acquired old neglected drugs and sharply raised their prices. Retrophins board fired Mr. Shkreli a year ago. Last month, it filed a complaint in Federal District Court in Manhattan, accusing him of using Retrophin as a personal piggy bank to pay back angry investors in his hedge fund.
Mr. Shkreli has denied the accusations. He has filed for arbitration against his old company, which he says owes him at least $25 million in severance. They are sort of concocting this wild and crazy and unlikely story to swindle me out of the money, he said."
Capitalism Unchained.
And people hate pharmaceutical companies why again? Many of them make massive profits off from the suffering of others who have no other choice but to use their products to alleviate their suffering. It's inhuman.
Oh wait! That can't be right because "Corporations are people, my friend."
How about this ?
He has said that he raised the price in order to raise funds for other drug production by his company. Who knows when or how much of these new "funds" will make their way into research or development, and how much will make it's way into his pocket. One of the articles says he is using the windfall profit to pay off hedge fund investors.
He's a crook. (crook and criminal are not necessarily the same thing - crook is short for "crooked", dishonest,unfair, as Feronia says, an asshole)
IMO, which means nothing, I think there should be a cap on the profits one is allowed to make on drugs. These pharmaceutical companies are just making money on people's misery.
A 62 year old drug that works, now costs $750/pill? Ridiculous!
Why isn't this man in jail?
That's good!
Thankfully, I don't need it. Thanks for the offer, BF!
Those coupon things run out, too. They're usually only good for 3-4 refills, and then, it's back up to regular price.
I know, Hal. I'm not fond of our system, either.
''It's what you get when you marry capitalism and healthcare. The rest of the developed world figured that out long ago.''
BINGO
If anyone thinks this kind of financial practice is limited to drug prices , it's not . Oncologists are another specialty that gouges patients for money and declares a monopoly on legal treatments . And there are others ...
You are right, Petey!
As usual Petey tries to water down the topic by bringing in fringe information.
Fringe information ? Your whole topic is fringe information . The number of people affected by this price change is tiny . But the number of people affected by oncologists is enormous ...
As usual, your meandering thoughts twist and turn off the beaten path. Sounds interesting on the face of it, but most of your meanderings are duds and dead ends, not to mention the deliberate derailments.
I am not sure you have ever simply addressed the seeded topic.
Tracks are for the conventional stodgy types !
Just saw this story on the news, and Shkreli comes off as even a bigger jerk. It seems he saw the chance to corner the market on a little used drug (10-12,000 patients a year) and just exploit the market and make himself rich. The fact that there will inevitably be middle class people who will now have to needlessly pay thousands or tens of thousands of dollars for the drug, each, doesn't effect him a bit.
You know, I don't often say such things, but it wouldn't bother me a bit to hear that he walked out of his office this evening and got run over by an eighteen wheeler.
In theory you have a point. In practice, you rarely have one worth the trouble.
If you weren't so lazy, you would start your own seed about the cost of oncologists.
I thought about doing that . It would take a lot of careful research . It would also require a legal disclaimer that the info presented is not to be considered official medical advice . However , if someone has questions about this issue feel free to email them to me .